language_icon
EN
HI

Advanced Enzyme Technologies Share price

ADVENZYMES

365.25

2.70 (-0.73%)
NSE
BSE
Last updated on 14 May, 2026 | 15:44 IST
Today's High

379.95

Today's Low

363.30

52 Week Low

251.95

52 Week High

419.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Advanced Enzyme Technologies Chart

Advanced Enzyme Technologies Share Key Metrics

Volume
2.92 L
Market Cap
4088.13 CR
LTQ@LTP
7@365.25
ATP
369.13
Var Margin
19.76 %
Circuit Range
294.4-441.5
Delivery %
35.47 %
Value
10.78 CR
ASM/GSM
No
Market Lot
1

Summary

Advanced Enzyme Technologies share price stands at ₹365.25 at 14 May, 2026 | 15:44. The stock Advanced Enzyme Technologies intraday movement has stayed between ₹363.30 and ₹379.95, while on a 52-week basis it has fluctuated from ₹251.95 to ₹419.00.
In terms of trading activity, Advanced Enzyme Technologies has recorded a volume of 292102 shares. The Advanced Enzyme Technologies has a market cap of ₹111926800. The stock’s Average Traded Price (ATP) stands at ₹36913, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 7, 36525.
The Advanced Enzyme Technologies operates within a circuit range of ₹294.4-441.5 – ₹294.4-441.5, with a Value of ₹10.78 CR. The Delivery Percentage for the day is 35.47%. Additionally, Advanced Enzyme Technologies currently falls under the No framework, and trades with a market lot size of 1.

Advanced Enzyme Technologies Fundamentals

View More
P/E Ratio

24.48

P/B Ratio

2.53

Div. Yield

0.37

Sector P/E

66.86

Sector P/B

3.47

Sec. Div. Yield

0.56

Advanced Enzyme Technologies Resistance and Support

Pivot 370.27

Resistance

First Resistance

377.04

Second Resistance

386.12

Third Resistance

392.89

Support

First Support

361.19

Second Support

354.42

Third Support

345.34

Advanced Enzyme Technologies Shareholding Pattern

View More
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
  • 2019-20
  • 2018-19
Total Promoters
Segment
Percent

Total Promoters

67.27%

Mutual Fund

7.3%

Insurance

0%

Foreign Institutional Investors

4.02%

Domestic Institutional Investors

0.4%

Retail

21%

Others

0.01%

Total Promoters
MAR '18
71.32%
JUN '18
67.34%
SEP '18
67.34%
DEC '18
67.27%

Advanced Enzyme Technologies Corporate Actions

DateAgenda
2026-05-09Audited Results & Dividend
2026-01-31Quarterly Results
2025-11-12Quarterly Results
2025-08-02Quarterly Results
2025-05-13Audited Results
2025-02-08Quarterly Results

Advanced Enzyme Technologies News

Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Advanced Enzyme Tech released the audio recording of its conference call held on May 12, 2026. The call discussed the audited financial results for the quarter and year ended March 31, 2026, and is available on the company's website.
May 12 2026 15:05:00

Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Advanced Enzymes Technologies Ltd. announced its Q4 FY26 consolidated results via a press release, with revenue growing 22% YoY to Rs.203.4 crore and net profit increasing 69% to Rs.45.3 crore. Full year FY26 net profit also rose 30% YoY.
May 09 2026 15:05:00

Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Cancellation of Dividend

Advanced Enzymes' Board deferred the interim dividend declaration. The company stated this decision aims to preserve capital to provide flexibility for evaluating strategic avenues and maximizing long-term shareholder value.
May 09 2026 14:05:00

Advanced Enzyme Technologies Ltd - 540025 - Corporate Action-Board approves Dividend

Advanced Enzymes recommended a final dividend of ₹1.35 per equity share for FY26. The board deferred the interim dividend to preserve capital for future strategic flexibility.
May 09 2026 13:05:00

Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Advanced Enzyme Technologies will host a conference call on May 12, 2026, at 9:00 AM IST, for analysts and investors. The call will discuss the financial results for the quarter and year ended March 31, 2026.
May 05 2026 17:05:00

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Ltd. Board will meet on May 09, 2026. The agenda includes approving annual and Q4 FY26 financial results, and considering both final FY26 and interim FY27 dividends.
May 02 2026 18:05:00

Advanced Enzyme Technologies Limited

Advanced Enzyme board will convene on May 9, 2026, to approve the audited yearly financial results for the period ended March 2026. The meeting will also consider the recommendation of both final and interim dividends.
May 02 2026 18:05:00
Read More

About Advanced Enzyme Technologies

NSE : 18039  
BSE : 540025  
ISIN : INE837H01020  

The Company was incorporated as a private limited company on March 15 1989 under the provisions of the Companies Act 1956 as Advanced Biochemicals Private Limited in Maharashtra. Pursuant to a special resolution passed by the shareholders of the Company at the extra-ordinary general meeting held on April 21 1992 the Company was converted into a public limited company and consequently the name of the Company was changed to Advanced Biochemicals Limited. A fresh certificate of incorporation reflecting the new name was issued by the Registrar of Companies Maharashtra on May 28 1992. Pursuant to a special resolution passed by the shareholders of the Company at the extraordinary general meeting held on August 8 2005 the name of the Company was further changed from Advanced Biochemicals Limited to Advanced Enzyme Technologies Limited. A fresh certificate of incorporation reflecting the new name was issued by the Registrar of Companies Maharashtra Mumbai on August 19 2005.Major events in the History of the Company1989 - Incorporation as Advanced Biochemicals Private Limited.1992 - Conversion from private company into a public company and renamed as Advanced Biochemicals Limited.1994 - Commissioning of the first fermentation facility at Sinnar Maharashtra2001 - Recognition of in-house R&D centers of the Company at Thane and Sinnar by the Department of Scientific and Industrial Research Ministry of Science and Technology Government of India.2005 - Change of name of the Company from Advanced Biochemicals Limited to Advanced Enzyme Technologies Limited.2011 - Takeover of Cal-India Foods International (Specialty Enzymes and Biotechnologies) by the Company giving us direct presence in USA.2012 - Kotak India Venture Fund I Kotak Employees Investment Trust and Kotak India Venture (Offshore) Fund made an investment in the Company.2012 - Takeover of AST Enzymes by the Company for consolidating the presence in USA.Awards and accreditations received by the Company2010 - The Company won the “Emerging India Awards” for 2010 in the Life Science -Pharmaceuticals & Chemicals segment organized by ICICI Business Banking and CNBC TV18.2010 - The Company won the Bio Excellence Award in the Industrial Biotech category for 2010 instituted by Department of Information Technology Biotechnology and Science and Technology Government of Karnataka.2012 - The Company was awarded as the 1st runner-up for the Most Innovative Exporter – Dun & Bradstreet for the year 2012.2013 - The Company was one of the Recipients of the fastest growing mid-sized business award organized by Inc. India.2014 - The Company received the Bio Excellence Award in the Industrial Biotech category for year 2014 instituted by Department of Information Technology Biotechnology and Science and TechnologyGovernment of Karnataka.

Read More

Advanced Enzyme Technologies Management

NamePosition
Sanjay BasantaniCompany Secretary & Compliance Officer, Head-Legal
Vasant RathiChairman
View More

Advanced Enzyme Technologies FAQs

The Buying Price of Advanced Enzyme Technologies share is 365.25 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Advanced Enzyme Technologies stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Advanced Enzyme Technologies, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Advanced Enzyme Technologies shares is 24.48. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Advanced Enzyme Technologies shares is 2.53. Useful to assess the stock's value relative to its book value.

To assess Advanced Enzyme Technologies’s valuation compare Sector P/E, P/B which are 66.86 & 3.47 with sector averages, along with growth rates and financial metrics.

The Market Cap of Advanced Enzyme Technologies is 4088.13 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Advanced Enzyme Technologies share price is 419.00 & 251.95. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Advanced Enzyme Technologies belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost